The Greek company Kalacan Hellas S.A. recently announced that it had received its medical cannabis installation license, allowing the company to establish manufacturing facilities in Europe to produce cannabis.
The company plans on building its large-scale greenhouses on a 77,258 square-meter (831,598 square foot) licensed plot in the region of Kalamata, Greece, including EU GMP processing and manufacturing facilities. Such facilities are designed for the professional manufacture and packaging of pharmaceutical products.
Construction is expected to begin later within this year.
– Read the entire article at Greek Reporter.